Broader benefits of the polio programme, GPEI partners, Transition planning, Vaccines
Coffee with Polio Experts: Anand Balachandran, WHO
Anand Balachandran, former Coordinator Polio Transition, speaks to us about ensuring the infrastructure built up to eradicate polio will continue to benefit broader public health goals, long after the disease has been eradicated.
07 September 2021
Learn how the type 2 novel oral polio vaccine (nOPV2) is being rolled out across Africa to help more sustainably address outbreaks of a non-wild form of polio, cVDPV2, and protect children across the continent.
Despite success against wild polio in the African region, outbreaks of the non-wild form of polio, cVDPV2, continue. With continued country commitment to eradication, a future where no child in Africa is paralysed by the virus is possible.
Afghanistan’s Polio Eradication Initiative continues operations amidst ongoing instability in the country
19 August 2021
Value of polio infrastructure in COVID-19 support continues to be highlighted